abstract |
The present invention relates to the discovery that interleukin-17 ligands and receptor family members, and IL-17 receptor A and IL-17 receptor C, form biologically active heterologous receptor complexes. An antagonist of the IL-17RA-IL-17RB heterologous receptor complex, and various methods of use are disclosed. |